Table 3.
Comparison of reported curcumin bioavailabilities among commercial preparations in healthy human subjects.
Product | Increased Relative Bioavailability | Reference |
---|---|---|
CUMINUP60® | 178-fold | This study |
BioCurc® | 94-fold | [45] |
BCM-95® | 6.9-fold | [46] |
CAVACURMIN® | 40-fold | [47] |
Curcugen® | 49.5-fold | [48] |
Curcumin C3 Complex® | 1.1-fold | [49] |
curcuRouge® | 91.8-folda | [50] |
CurcuWin® | 45.9-fold | [51] |
Cureit® | 10-fold | [52] |
CurQfen® | 45.5-fold | [53] |
Longvida® | 100-fold | [54] |
Meriva® | 29-fold | [55] |
MicroActive® Curcumin SR | 9.7-fold | [19] |
NovaSOL® | 185-fold | [42] |
Theracurmin® | 27-fold | [22] |
TurmiPure Gold® | 24.2-fold | [49] |
TurmXTRA® 60 N | 10-fold | [56] |
Calculated based on comparison with Theracurmin®.